← Browse by Condition
Medical Condition

septic shock

Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2, Phase 3, Phase 4

ClinicalMetric tracks all active clinical trials for septic shock sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — septic shock Clinical Trials

How many clinical trials are currently recruiting for septic shock?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for septic shock, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for septic shock?
septic shock research spans Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a septic shock clinical trial?
Eligibility criteria for septic shock trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Phase 4
2
Top Sponsors
Ottawa Hospital Research Institute 1 trial
Insel Gruppe AG, University Hospital Bern 1 trial
Ain Shams University 1 trial
Jamil Cedeño Mora 1 trial
Avicenna Military Hospital 1 trial

Recruiting Clinical Trials

NCT05969275 Phase 2
Recruiting
Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock
Enrollment
296 pts
Location
Canada
Sponsor
Ottawa Hospital Research Insti...
View Trial →
NCT03892174
Recruiting
Cytokine REmoval in CRitically Ill PAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE)
Enrollment
54 pts
Location
Switzerland
Sponsor
Insel Gruppe AG, University Ho...
View Trial →
NCT07550400
Recruiting
Role of Echocardiography and Ultrasound Indices in Resuscitation of Septic Shock Patients
Enrollment
40 pts
Location
Egypt
Sponsor
Ain Shams University
View Trial →
NCT07255378
Recruiting
Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication
Enrollment
1,200 pts
Location
Spain
Sponsor
Jamil Cedeño Mora
View Trial →
NCT07096284
Recruiting
The PvCO2-PaCO2/CaO2-CvO2 Ratio in Septic Shock
Enrollment
30 pts
Location
Morocco
Sponsor
Avicenna Military Hospital
View Trial →
NCT04931225 Phase 3
Recruiting
LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)
Enrollment
44 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT07779720
Recruiting
Personalized Fluid Resuscitation in the Emergency Department: A Pilot Trial
Enrollment
40 pts
Location
United States
Sponsor
Intermountain Health Care, Inc...
View Trial →
NCT07383103 Phase 4
Recruiting
Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock
Enrollment
336 pts
Location
China
Sponsor
Northern Jiangsu People's Hosp...
View Trial →
NCT06853340
Recruiting
Impact of Vascular Calcification and CASR Expression by Monocytes in Septic Shock
Enrollment
66 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT06570187 Phase 4
Recruiting
The Effect of Dexmedetomidine on the Renal Functions in Septic Critically Ill Patients
Enrollment
128 pts
Location
Egypt
Sponsor
Cairo University
View Trial →

Related Conditions

sepsis (4) inflammation (2) pathologic processes (1) shock (1) systemic inflammatory response syndrome (1) infections (1) endocarditis (1) fluid resuscitation (1) calcium sensing receptor (1) calcium phosphate disorders (1) monocyte (1) acute kidney injury (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology